Sg Americas Securities, LLC Uro Gen Pharma Ltd. Transaction History

Sg Americas Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$10.87 - $15.93 $94,645 - $138,702	8,707 New	8,707 $131,000
Q4 2021 Feb 07, 2022	SELL	$9.03 - $19.13 $93,171 - $197,383	-10,318 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$14.31 - $18.39 $147,650 - $189,748	10,318 New	10,318 $174,000
Q2 2021 Aug 12, 2021	SELL	$15.2 - $20.94 $79,572 - $109,620	-5,235 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$17.99 - $26.96 $917,651 - $1.38 Million	-51,009 Reduced 90.69%	5,235 $102,000

Q4 2020 Feb 04, 2021	SELL	$17.54 - $25.43 $96,329 - $139,661	-5,492 Reduced 8.9%	56,244 $1.01 Million
Q3 2020 Nov 09, 2020	SELL	$18.81 - $26.42 $1.32 Million - $1.85 Million	-69,914 Reduced 53.11%	61,736 $1.19 Million
Q2 2020 Jul 20, 2020	BUY	$16.5 - $29.7 $495,874 - $892,574	30,053 Added 29.58%	131,650 $3.44 Million
Q1 2020 Apr 30, 2020	BUY	$13.68 - $34.6 $701,195 - $1.77 Million	51,257 Added 101.82%	101,597 $1.81 Million
Q4 2019 Jan 28, 2020	BUY	$21.11 - $34.86 $12,349 - $20,393	585 Added 1.18%	50,340 $1.68 Million
Q3 2019 Nov 04, 2019	BUY	$23.83 - $36.44 $1.19 Million - $1.81 Million	49,755 New	49,755 $1.19 Million

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.